Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pseudomyxoma Peritonei × Sirolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Myelodysplastic Syndromes 27 Leukemia, Myeloid, Acute 27 Hodgkin Disease 24 Lymphoma, Non-Hodgkin 23 Multiple Myeloma 22 Lymphoma 20 Leukemia 20 Graft vs Host Disease 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Myeloproliferative Disorders 14 Lymphoma, Mantle-Cell 14 Tuberous Sclerosis 12 Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Hematologic Neoplasms 12 Burkitt Lymphoma 12 Primary Myelofibrosis 11 Recurrence 10 Neoplasms, Plasma Cell 10 Lymphoma, Follicular 10 Leukemia, Myelomonocytic, Chronic 10 Waldenstrom Macroglobulinemia 9 Sarcoma 9 Neoplasm Metastasis 9 Lymphoma, B-Cell, Marginal Zone 9 Lymphangioleiomyomatosis 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 3 Fluorouracil 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 Tacrolimus 1 Surveys and Questionnaires 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Oxaliplatin 1 Observation 1 Methods 1 Leucovorin 1 Lansoprazole 1 Ifosfamide 1 Gemcitabine 1 Early Intervention, Educational 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 Cisplatin 1 Carboplatin 1 Behavior Therapy 1 Amoxicillin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡